Mylan announces commercial launch of its Remdesivir under brand name DESREM in India

Jul 20, 2020

New Delhi/Bengaluru [India], July 20 : Pharmaceutical company Mylan on Monday announced the commercial launch of its Remdesivir under the brand name DESREM in...

Nitin Gadkari directs Nagpur DC to distribute Remdesivir injections to other districts of Vidarbha

Apr 12, 2021

New Delhi [India], April 12 : Union Minister Nitin Gadkari on Monday directed Nagpur District Collector Ravindra Thackeray to distribute Remdesivir injections received through...

Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial

Jul 07, 2020

Bengaluru (Karnataka) [India], July 7 : Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI)...

Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%

Sep 21, 2021

Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S....

DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients

Jul 02, 2020

New Delhi [India], July 2 : The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the...

COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesivir drug

Jun 04, 2020

New Delhi [India], June 4 : Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of...